The global next generation sequencing (NGS) market is expected to exceed more than US$ 12445 million by 2022 and is projected to register a compound annual growth rate (CAGR) of more than 20% during the forecast period. The technological advancements in sequencing platforms and increasing applications of NGS are expected to drive the market. In addition, the increasing adoption of NGS technologies among research laboratories and academic institutes and conferences and workshops increasing awareness on NGS products and services are expected to fuel the growth of the market. However, the dearth of skilled professionals and difficulties in the storage of sequencing data are expected to hamper the growth of the market.
In this report, the global next generation sequencing market is segmented by workflow, application, end user, and region. On the basis of workflow, the market is segmented into NGS pre-sequencing, NGS data analysis, and NGS sequencing. The market on the basis of application is segmented into HLA testing, oncology, prenatal testing, idiopathic diseases, and infectious diseases. The market by end user is segmented into academic research, hospitals & clinics, clinical research, pharma & biotech entities, and others. By technology, the market is segmented into whole genome sequencing, whole exome sequencing, and targeted sequencing & resequencing.
The global next generation sequencing market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, and Rest of the World. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Russia, Brazil, and GCC countries. The report includes a detailed study of the global and regional next generation sequencing market and analyzes the variations in the growth of the industry in certain regions.
A glimpse of the report structure is provided in the report description available on the website.
Pacific Biosciences, Beijing Genomics Institute, Illumina Inc., 454 Life Sciences Corp. (Roche Holding Ag), GATC Biotech Ag., Life Technologies (Thermo Fisher Scientific), Oxford Nanopore Technologies Inc., Agilent Technologies Inc., Biomatters Ltd., Dnastar Inc., Macrogen Inc., HelicosBioSciences, Clc Bio (Qiagen), and Knome Inc. are the most active players in the next generation sequencing market.
This report covers the next generation sequencing market, in terms of value, and forecasts the market size till 2022. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org